Immunotherapy in Advanced Biliary Tract Cancers

SIMPLE SUMMARY: A new era has emerged in oncology in the last ten years with the development of immune therapies. However, single-agent immune therapy such as immune checkpoint inhibitors seems to have a limited clinical activity in biliary tract cancers and are still largely investigational, except...

Descripción completa

Detalles Bibliográficos
Autores principales: Boilève, Alice, Hilmi, Marc, Smolenschi, Cristina, Ducreux, Michel, Hollebecque, Antoine, Malka, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036747/
https://www.ncbi.nlm.nih.gov/pubmed/33805461
http://dx.doi.org/10.3390/cancers13071569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036747/
https://www.ncbi.nlm.nih.gov/pubmed/33805461
http://dx.doi.org/10.3390/cancers13071569

Ejemplares similares